Revenue · 2011–2025
Regeneron Pharmaceuticals revenue
$14.3B+1.0% · FY2025
Regeneron Pharmaceuticals (REGN) reported $14.3B in revenue for fiscal 2025, +1.0% year on year.
| Fiscal year | Revenue | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $14.3B | +1.0% | Open → |
| FY20242024-12-31 | $14.2B | +8.3% | Open → |
| FY20232023-12-31 | $13.1B | +7.8% | Open → |
| FY20222022-12-31 | $12.2B | −24.3% | Open → |
| FY20212021-12-31 | $16.1B | +89.1% | Open → |
| FY20202020-12-31 | $8.5B | +29.6% | Open → |
| FY20192019-12-31 | $6.6B | +27.4% | Open → |
| FY20182018-12-31 | $5.1B | −12.4% | Open → |
| FY20172017-12-31 | $5.9B | +20.8% | Open → |
| FY20162016-12-31 | $4.9B | +18.4% | Open → |
| FY20152015-12-31 | $4.1B | +45.5% | Open → |
| FY20142014-12-31 | $2.8B | +34.0% | Open → |
| FY20132013-12-31 | $2.1B | +52.7% | Open → |
| FY20122012-12-31 | $1.4B | +209.2% | Open → |
| FY20112011-12-31 | $446M | — | Open → |
Revenue — Revenue is total net sales for the fiscal year, taken from each company's own annual filing.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth +28.1%
Revenue at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Regeneron Pharmaceuticals revenue |url=https://companiesranked.com/en/company/regeneron-pharmaceuticals/revenue |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Regeneron Pharmaceuticals revenue. CompaniesRanked. https://companiesranked.com/en/company/regeneron-pharmaceuticals/revenueBibTeX
@misc{companiesranked-en-company-regeneron-pharmaceuticals-revenue-2026,
author = {{CompaniesRanked}},
title = {{Regeneron Pharmaceuticals revenue}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/regeneron-pharmaceuticals/revenue}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-K · 0000872589-26-000008 · February 4, 2026
{{cite web |title=Regeneron Pharmaceuticals revenue — 10-K (0000872589-26-000008) |url=https://www.sec.gov/Archives/edgar/data/872589/000087258926000008/regn-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-04}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.